Evidence map›Paper›PMID 30587799›Full record

ArticleMolecules (Basel, Switzerland)2018

Neo-5,22

Biyu Lv, Weiping Yin, Jiayu Gao, Huaqing Liu, Kun Liu, Jie Bai, Qiangqiang Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Discovery of Guanidine Derivatives fromMolecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Biyu LvSchool of Chemical Engineering and Pharmaceutics, Henan University of Science and Technology, Luoyang 471023, China. biyulv0827@163.com.
Weiping YinSchool of Chemical Engineering and Pharmaceutics, Henan University of Science and Technology, Luoyang 471023, China. yinwp@haust.edu.cn.
Jiayu GaoSchool of Chemical Engineering and Pharmaceutics, Henan University of Science and Technology, Luoyang 471023, China. cruise1024@163.com.
Huaqing LiuSchool of Chemical Engineering and Pharmaceutics, Henan University of Science and Technology, Luoyang 471023, China. lhq@126.com.
Kun LiuSchool of Chemical Engineering and Pharmaceutics, Henan University of Science and Technology, Luoyang 471023, China. liukun1988china@163.com.
Jie BaiSchool of Chemical Engineering and Pharmaceutics, Henan University of Science and Technology, Luoyang 471023, China. bj@126.com.
Qiangqiang YangLife Science and Environmental Science Research Center of Harbin University of Commerce, Harbin 150025, China. 18568105396@163.com.
Henan University of Science and Technology · CNHarbin University of Commerce · CN

Funding

National Natural Science Foundation of China Grant No. 21472035.
6 · The paper itself

Abstract

The discovery and search for new antimicrobial molecules from insects and animals that live in polluted environments is a very important step in the scientific search for solutions to the current problem of antibiotic resistance. Previously, we have reported that the secondary metabolite with the antibacterial action discovered in scorpion. The current study further isolated three new compounds from

Indexed as

AnimalsAnti-Bacterial AgentsBacteriaCholestadienolsMagnetic Resonance SpectroscopyMicrobial Sensitivity TestsMolecular StructureScorpionsStructure-Activity RelationshipAnti-Bacterial AgentsCholestadienolsbroad-spectrum bactericideButhus martensii karschmolecular dockingnatural productsnovel 5,22E-cholestadienol compoundssecondary metabolitesstructures elucidatedtargeted action mechanisms

Identifiers

PMID30587799
PMCPMC6337218
OpenAlexW2906184480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.